ConductScience.org, home

Paper6633596

Progesterone receptors as a prognostic factor in Stage II breast cancer.

Clark GM and 4 others. N Engl J Med, 1983. Cited by 417 papers, by iCite.

Cite this record

ConductScience Library. Progesterone receptors as a prognostic factor in Stage II breast cancer. Papers, record 6633596. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6633596

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Progesterone receptors as a prognostic factor in Stage II breast cancer.
PubMed
Journal
N Engl J Med
PubMed
Year
1983
PubMed
Publication types
Clinical Trial, Journal Article, Randomized Controlled Trial, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
417
iCite
Relative citation ratio, by iCite
13.2
iCite
Revised in PubMed
2019-08-25
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Clark GMG M
2McGuire WLW L
3Hubay CAC A
4Pearson OHO H
5Marshall JSJ S

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Breast NeoplasmsMajor topic
Receptors, ProgesteroneMajor topic
Female
Humans
Lymphatic Metastasis
Neoplasm Staging
Prognosis
Receptors, Estrogen
Statistics as Topic

Source PubMed

Download CSV of topics

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
CA 30195NCI NIH HHSUnited StatesP01CA030195PubMed and NIHNIH RePORTER
CB 23922NCI NIH HHSUnited StatesPubMedPubMed

Download CSV of grants

Cited by78

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 417 citations.

PMIDTitleJournalYearIn PapersSource
35201434The impact of endogenous estrogen exposures on the characteristics and outcomes of estrogen receptor positive, early breast cancer.Discov Oncol2021https://conductscience.org/library/papers/35201434PubMed
33613796Percentage of Hormone Receptor Positivity in Breast Cancer Provides Prognostic Value: A Single-Institute Study.J Clin Med Res2021https://conductscience.org/library/papers/33613796PubMed
30407916Low PR in ER(+)/HER2(-) breast cancer: high rates of TP53 mutation and high SUV.Endocr Relat Cancer2019https://conductscience.org/library/papers/30407916PubMed
30312199Implications for Breast Cancer Restaging Based on the 8th Edition AJCC Staging Manual.Ann Surg2020https://conductscience.org/library/papers/30312199PubMed
29435103Progesterone receptor isoforms, agonists and antagonists differentially reprogram estrogen signaling.Oncotarget2018https://conductscience.org/library/papers/29435103PubMed
28861319Steroid hormone receptors as prognostic markers in breast cancer.Am J Cancer Res2017https://conductscience.org/library/papers/28861319PubMed
28569250Interleukin 8 in progression of hormone-dependent early breast cancer.J Biosci2017https://conductscience.org/library/papers/28569250PubMed
27872526Progesterone Receptors, Pathological Complete Response and Early Outcome for Locally Advanced Breast Cancer - a Single Centre Study. (PPLB - 01).Indian J Surg Oncol2016https://conductscience.org/library/papers/27872526PubMed
25998416From bench to bedside: What do we know about hormone receptor-positive and human epidermal growth factor receptor 2-positive breast cancer?J Steroid Biochem Mol Biol2015https://conductscience.org/library/papers/25998416PubMed
25268975Synthesis, characterization and in vitro study of biocompatible cinnamaldehyde functionalized magnetite nanoparticles (CPGF Nps) for hyperthermia and drug delivery applications in breast cancer.PLoS One2014https://conductscience.org/library/papers/25268975PubMed
24906430HITS-CLIP reveals key regulators of nuclear receptor signaling in breast cancer.Breast Cancer Res Treat2014https://conductscience.org/library/papers/24906430PubMed
24637666Inferring gene dependency network specific to phenotypic alteration based on gene expression data and clinical information of breast cancer.PLoS One2014https://conductscience.org/library/papers/24637666PubMed
24527034Breast cancer pathology, receptor status, and patterns of metastasis in a rural appalachian population.J Cancer Epidemiol2014https://conductscience.org/library/papers/24527034PubMed
24199171In situ Protein Detection for Companion Diagnostics.Front Oncol2013https://conductscience.org/library/papers/24199171PubMed
23251644Cutoff Finder: a comprehensive and straightforward Web application enabling rapid biomarker cutoff optimization.PLoS One2012https://conductscience.org/library/papers/23251644PubMed
22108646The association between vitamin D receptor expression and prolonged overall survival in breast cancer.J Histochem Cytochem2012https://conductscience.org/library/papers/22108646PubMed
21459801Progesterone receptor isoform-specific promoter methylation: association of PRA promoter methylation with worse outcome in breast cancer patients.Clin Cancer Res2011https://conductscience.org/library/papers/21459801PubMed
20150438Multiplexed assessment of the Southwest Oncology Group-directed Intergroup Breast Cancer Trial S9313 by AQUA shows that both high and low levels of HER2 are associated with poor outcome.Am J Pathol2010https://conductscience.org/library/papers/20150438PubMed
19701242Biological determinants of endocrine resistance in breast cancer.Nat Rev Cancer2009https://conductscience.org/library/papers/19701242PubMed
19064545Triple-negative breast cancer and obesity in a rural Appalachian population.Cancer Epidemiol Biomarkers Prev2008https://conductscience.org/library/papers/19064545PubMed

See all 78 cited byDownload CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ESR12099PubTator's text mininghttps://conductscience.org/library/genes/2099NCBI Gene
PGR5241PubTator's text mininghttps://conductscience.org/library/genes/5241NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/6633596

GET https://conductscience.org/api/papers/v1/6633596/cited_by?page=2